• Validated HPLC for Trelagliptin Succinate Impurities

  2026-08-20

  The reference study developed and validated a stability-indicating HPLC method that separates trelagliptin succinate from eight potential process-related impurities and stress-generated degradation products. Its combination of chromatographic validation, forced-degradation testing, and UHPLC–Orbitrap mass spectrometry provides a practical framework for quality control in dosage-form development.

• Ertugliflozin (PF-04971729) Research Workflows

  2026-08-19

  Build reproducible renal transport, metabolic, and brain insulin-signaling experiments with the highly selective SGLT2 inhibitor PF-04971729. This workflow-focused guide connects glucose reabsorption inhibition with translational Alzheimer’s disease research while emphasizing compound handling, assay controls, and troubleshooting.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-19

  Breen and colleagues developed a genetically drug-sensitized yeast platform that detects TOR/mTOR pathway inhibitors at substantially lower concentrations than conventional wild-type yeast assays. The system distinguished known TOR inhibitors, identified aminophylline as a TOR1-dependent growth inhibitor, and found no evidence of TOR inhibition by Canagliflozin under the tested conditions.

• Artesunate Workflows for Cancer Cell Death

  2026-08-18

  Artesunate enables cancer researchers to distinguish growth inhibition from true cell killing while probing ferroptosis, pyroptosis-related signaling, and AKT/mTOR responses. This practical guide covers stock preparation, time-resolved assays, model selection, and troubleshooting for small cell lung carcinoma and esophageal squamous cell carcinoma studies.

• Berberine Hydrochloride in Gut–Bone Assays

  2026-08-18

  Build reproducible berberine hydrochloride workflows for gut–bone, metabolic, microbiome, and cell-death research. This guide translates a tuft-cell study into practical assay choices while addressing solubility, salt-form comparisons, controls, and readout optimization.

• Ganetespib (STA-9090) Research Workflow Guide

  2026-08-17

  Ganetespib (STA-9090) combines nanomolar Hsp90 inhibition with a practical workflow for studying client-protein loss, cancer-cell viability, and tumor growth inhibition. This guide translates its triazolone chemistry into reproducible assay design while using a norovirus secretion study to sharpen compartment-specific readouts.

• Cy5 Hydrazide for Carbonyl Labeling in Nanotech

  2026-08-17

  Cy5 hydrazide converts otherwise difficult-to-measure aldehyde and ketone modifications into a far-red fluorescence signal for protein carbonylation labeling, glycoprotein analysis, and nanoparticle-interface studies. Its strong optical response and SDS-PAGE compatibility are balanced by a practical requirement: prepare the non-sulfonated dye in an organic co-solvent and remove unreacted material before quantification.

• Cyclopamine: Hedgehog Signaling Inhibitor Workflow

  2026-08-16

  Build reproducible Hedgehog pathway experiments with Cyclopamine, from DMSO handling and dose-response design to apoptosis and proliferation readouts. The workflow also translates recent papillary thyroid carcinoma findings into practical combination, knockdown, and validation strategies for cancer research.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-08-15

  The Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, provides affinity-purified detection of HMGB1 in human, mouse, and rat samples for Western blot, immunohistochemistry, and flow cytometry workflows. The APExBIO dossier supports research use only; it does not establish diagnostic, therapeutic, or paper-specific performance claims.

• Sumatriptan Succinate: 5-HT1 Receptor Agonist

  2026-08-14

  Sumatriptan Succinate is a selective 5-HT1 receptor agonist used for acute migraine research and treatment. Its validated 5-HT1B/1D pharmacology is complemented by updated evidence that both MAO A and selected CYP enzymes participate in its metabolism.

• Berberine Hydrochloride: Assay Design

  2026-08-14

  Berberine hydrochloride connects AMPK-centered metabolic assays with gut–bone and osteoimmune research. This article presents a causal, assay-first framework for separating direct cellular effects from microbiome-mediated outcomes and selecting controls for translational studies.

• Sumatriptan: Receptor Selectivity and Metabolism

  2026-08-13

  Sumatriptan Succinate is more than a standard 5-HT1 receptor agonist: its receptor pharmacology and unexpectedly layered metabolism can reshape assay design. This guide connects 5-HT1B/1D signaling, CGRP biology, inflammation models, and metabolite-aware experimental controls.

• Phosphatase Inhibitor Cocktail 2: Workflow Guide

  2026-08-13

  Protect phosphorylation-dependent biology from lysis through Western blotting, co-immunoprecipitation, pull-down, and kinase assays with a practical 100X workflow. This guide combines broad phosphatase control with low-temperature, rationally simplified assay design inspired by recent DT-TRAP findings.

• ASCH Proteins and N4-Acetylcytidine Processing

  2026-08-12

  Meng et al. define how the E. coli ASCH-domain protein EcYqfB hydrolyzes free N4-acetylcytidine while showing that it does not remove ac4C from RNA. Structural comparisons with mouse EOLA1 and the human TRIP4-ASCH domain reveal divergent substrate preferences, providing a framework for interpreting ASCH proteins in RNA metabolism and nucleotide processing.

• (-)-JQ1: A Rigorous BET Control Workflow

  2026-08-12

  (-)-JQ1 is an inactive JQ1 stereoisomer designed to separate BET bromodomain-dependent effects from vehicle, scaffold, and off-target responses. This practical workflow shows how to pair it with active JQ1, reporter assays, and cell-to-animal screening strategies for more defensible epigenetics and cancer biology research.

8647 records 6/577 page Previous Next First page 上5页 678910 下5页 Last page